Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0D3YL
|
|||
| Former ID |
DNC005644
|
|||
| Drug Name |
(5-Phenyl-oxazol-2-yl)-m-tolyl-amine
|
|||
| Synonyms |
GW632046X; N-(3-methylphenyl)-5-phenyl-1,3-oxazol-2-amine; 2-Anilino-5-aryloxazole 14; AC1NS7RH; SCHEMBL5475472; CHEMBL192417; BDBM5853; HMS3305J21; HMS3303N24; NCGC00242232-01
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H14N2O
|
|||
| Canonical SMILES |
CC1=CC(=CC=C1)NC2=NC=C(O2)C3=CC=CC=C3
|
|||
| InChI |
1S/C16H14N2O/c1-12-6-5-9-14(10-12)18-16-17-11-15(19-16)13-7-3-2-4-8-13/h2-11H,1H3,(H,17,18)
|
|||
| InChIKey |
XLGKHWGSIZWZNN-UHFFFAOYSA-N
|
|||
| PubChem Compound ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Discovery and evaluation of 2-anilino-5-aryloxazoles as a novel class of VEGFR2 kinase inhibitors. J Med Chem. 2005 Mar 10;48(5):1610-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.